Nisa Leung is a venture capitalist who served as Managing Partner at Qiming Venture Partners for 19 years. See sector focus and contact routes.
Nisa Leung is a venture capitalist who served as Managing Partner at Qiming Venture Partners for 19 years, where she founded and led the firm’s healthcare practice starting in 2006, before departing in February 2025. Widely recognized as China’s leading investor in healthcare, her investment thesis centers on therapeutics, medical devices, diagnostics, healthcare services, and health tech, primarily within China. Qiming’s healthcare portfolio includes over 200 companies, with Leung backing more than 30 of China’s healthcare giants, focusing on solving incurable diseases. Typical check sizes and lead/follow behavior are not explicitly detailed in available sources, though Qiming has raised $9.4 billion across 11 funds with a strong emphasis on healthcare IPOs. Notable portfolio companies include Zai Lab, CanSino Biologics, Gan & Lee, and Tigermed, many of which are publicly listed or have achieved unicorn status. Leung distinguishes herself through her goal to address incurable diseases and holds roles such as visiting lecturer at Harvard Law School and board member of Hong Kong Exchanges and Clearing Limited.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Hong Kong.
Investors like Nisa Leung · Full investor directory · Investor access · Company funding database